Digital Health Global

NOVEMBER 30, 2023

Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Healthcare IT Today

NOVEMBER 7, 2023

A recent Deloitte study estimates the average cost of developing a single new drug at $2.3 This ML-driven adaptive process can significantly accelerate the clinical drug development process and increase certainty along the way, resulting in more efficient, targeted, and ultimately more successful clinical trials.

Drug Development 75

Drug Development BioTech Pharmaceuticals Health IT 75

Healthcare IT Today

JANUARY 7, 2025

As these implementations take hold, the emphasis will be on demonstrating measurable return on investment (ROI), with AI driving down administrative burdens, accelerating drug development, and significantly improving operational efficiency. What’s most exciting to me is AI’s potential impact on personalized medicine.

Health IT 93

Health IT Life Science Drug Development Pharmaceuticals 93

Digital Health Global

JANUARY 25, 2024

Biomarkers will help select patients whose cancer biologies are best suited to treatment with the right drug targeting the active disease mechanism. Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.

Drug Development 88

Drug Development Digital Health 88

Healthcare IT Today

JANUARY 8, 2024

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Riccardo Butta, President of the Americas at Stevanato Group In 2024, we can expect progress around men’s health, specifically in prostate cancer.

Health IT 93

Health IT Drug Development Pharmaceuticals BioTech 93

Digital Health Global

NOVEMBER 20, 2023

We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.” Evinova is a health-tech business within the AstraZeneca Group.

Life Science 88

Life Science Drug Development Digital Health Patient Experience 88

Digital Health Global

JUNE 20, 2023

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Healthcare IT Today

OCTOBER 6, 2023

The funding enables Atropos Health to accelerate commercial and development opportunities outside the U.S.,

Life Science 124

Life Science Drug Development Pharmaceuticals Health IT 124

Healthcare IT Today

NOVEMBER 14, 2022

Latest Round of Investment in the Family Engagement Technology Company Led by Bradford Whitmore and Mountain Group Partners, with Participation by SeedtoB Capital and the Rash Family Office. The Series B financing was led by Brad Whitmore and Mountain Group Partners (MGP), with participation from SeedtoB Capital and the Rash Family Office.

Life Science 96

Life Science HIPAA Drug Development healthcare technology 96

Healthcare IT Today

JANUARY 22, 2025

Katherine Seay, Executive Vice President at Clinical Trial Media Diversity in healthcare needs to extend to every corner of the industry, from healthcare practitioners to the drug development and discovery process. One area where the need for diversity has never been greater is clinical trials.

EHR 82

EHR Drug Development Remote care Interoperability 82

Society for Participatory Medicine

AUGUST 17, 2022

For a person like me, who is impacted by a rare, neurological, and incurable disease, it’s my mission to ensure that patients’ perspectives are represented early and throughout drug development. We plan to gather these stakeholders at the upcoming Huntington Study Group conference this November 3-5 in Tampa, FL, to develop next steps.

Drug Development 81

Drug Development BioTech 81

Digital Health Global

JANUARY 8, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI respectively. Medable, which ranked in the top 8% of software companies on the 2023 Inc.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Healthcare IT Today

MAY 22, 2023

“We are excited to have the support of such a strong group of investors who share our mission of unlocking the power of data to improve health,” said Sundeep Bhan, CEO at Prognos Health.

Life Science 69

Life Science Drug Development Health IT Healthcare IT 69

Society for Participatory Medicine

JANUARY 15, 2025

Make no mistake about it: health insurance companies like Cigna, Elevance, and UnitedHealth Group make billions of dollars in profit every single year. Steve Case & Revolution Health Group A few people have tried. Steve Case, the billionaire founder of America OnLine (AOL) launched a company called Revolution Health Group in 2005.

Drug Development 40

Drug Development Nursing 40

Digital Health Global

MAY 29, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment on average of $500K in Phase II and $1.5M

Drug Development 88

Drug Development Digital Health 88

Digital Health Global

JUNE 2, 2024

1 The collaboration between Massive Bio and Mika Health will also benefit the research both companies are performing with pharmaceutical companies and patient advocacy groups, by providing real-world data and insights into patient experiences and treatment outcomes.

Drug Development 88

Drug Development Pharmaceuticals Mental health Patient Experience 88

Digital Health Global

SEPTEMBER 27, 2023

With these resources, Automera is well positioned to deploy our AUTAC platform toward the development of potentially transformative therapies.” Automera’s AUTAC platform has broad potential across cancer and other disease areas, with oncology being the initial lead program.

Life Science 88

Life Science Drug Development HC BioTech 88

Digital Health Global

APRIL 16, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment on average of $500K in Phase II and $1.5M

Drug Development 88

Drug Development Pharmaceuticals Health science Digital Health 88

Digital Health Global

JANUARY 4, 2024

This new publication builds upon research conducted by Dr. Nitin Ohri at Montefiore Medical Center in collaboration with Koneksa, presented at 2023 ASCO Quality Care. Our evidence-based biomarker solutions enable efficient clinical trial designs to help innovative therapies reach patients faster.

Health Technology 88

Health Technology Digital Health Drug Development healthcare technology 88

Lloyd Price

NOVEMBER 21, 2023

Engage with Stakeholders: Actively engage with NHS staff, patients, and advocacy groups to understand their concerns and address them proactively. Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Open communication and collaboration will foster trust and support.

Drug Development 70

Drug Development Health science healthcare technology Leadership 70

Digital Health Global

FEBRUARY 16, 2023

“Avilar is pioneering the next frontier in protein degradation and we are excited that our significant progress over the past year in discovering and advancing extracellular protein degraders has attracted this group of leading investors,” said Daniel Grau, CEO and President of Avilar Therapeutics.

Life Science 88

Life Science BioTech Drug Development Digital Health 88

Insulin Nation

NOVEMBER 27, 2018

In his studies, Type 1 diabetic patients have significantly benefited when their daily insulin regimen is supplemented with drugs developed to treat Type 2 diabetes. His group also published a paper on ‘triple therapy’ which included liraglutide and dapagliflozin in addition to insulin in patients with type 1 diabetes.

Drug Development 70

Drug Development 70

Lloyd Price

MAY 18, 2021

Yaron Gissin, Chief Innovation Officer of the Sade Group, explores the benefits of individually personalised medicine via digital data and tools. A new medication is introduced to the market via legislation rather than through formal drug development practices (3); 3. PNAS Nov 2020; vol. 117(45) 2 Leader, The Economist.

Drug Development 64

Drug Development Pharmaceuticals Psychiatry Telemedicine 64

Digital Health Global

JANUARY 31, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment of on average of $500K in Phase 2 and $1.5M in Phase 3.

Health science 88

Health science Drug Development Digital Health Patient Experience 88

Lloyd Price

JUNE 4, 2018

and The Up Group recently hosted a breakfast on ‘Female Health Innovation’, often known as FemTech. CVC’s recent acquisition of the women’s health division of the Israeli drug developer Teva for $800m created a company dedicated to contraception, fertility, menopause and osteoporosis. Silicon Valley Bank, Zinc.vc

Mental health 49

Mental health Drug Development Health Data 49

Lloyd Price

APRIL 27, 2024

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. Collaboration between these groups will be crucial to unlocking the full potential of GenAI and shaping a healthier future for all. But how can healthcare organisations best leverage this technology?

healthcare technology 73

healthcare technology Leadership Drug Development Digital Health 73

Healthcare IT News - Telehealth

MAY 6, 2020

Biofourmis’ digital therapeutics are used for RPM across three primary healthcare stakeholder groups: health systems, payers and pharmaceutical companies. Typically, the health systems and payers work together in a value-based care arrangement that involves shared risk and reward.

Connected Health 216

Connected Health Telehealth Pharmaceuticals EHR 216

Healthcare Innovation Consortium

OCTOBER 24, 2023

We aim to bring together relevant stakeholders, including payers, providers, patients groups, and biotech and when and where needed we cooperate with pharma, to be the one voice of the industry. The pipeline for new antibiotics is limited, which is partly due to how new drug development is funded.

BioTech 60

BioTech Drug Development Healthcare Innovation Medical Technology 60

Healthcare IT Today

DECEMBER 27, 2022

Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A The company is headquartered in Lexington, Massachusetts. Click here for more information.

Pharmaceuticals 69

Pharmaceuticals Drug Development Medical Technology Healthcare IT 69

Xealth

JUNE 27, 2023

Its interest in DTx exists specifically in remote patient monitoring because of the potential to provide valuable insights throughout drug development life cycles. Big Pharma is driving much of the speculation. Several big players have joined the DTA, which doubled in membership in 2022. They include Astellas Pharma Inc.,

Digital Health 52

Digital Health Drug Development Pharmaceuticals Nursing 52

Digital Health Today

AUGUST 7, 2019

DTx could be used in phase II of clinical trials for monitoring patients, helping reduce costs of drug development and speeding up that phase. Healthcare professionals are a very important group to adopt DTx but education is essential for them to understand the benefits and how to use DTx.

Pharmaceuticals 70

Pharmaceuticals Digital Health Drug Development Primary Care 70

mHealth Insight

APRIL 24, 2018

The global pharmaceutical industry has seen a downturn in recent years because of the challenges and cost associated with pharmaceutical development, procrastination in drug development, etc. Victor Sastre, Senior MSL, Coordinator of the MSL Working Group AMIFE. Clinical trials field is also faced with such challenges.

Pharmaceuticals 28

Pharmaceuticals Drug Development 28

Digital Health Global

MAY 21, 2024

Food and Drug Administration, biomedical and life science companies, nonprofits, patient-focused groups, and other organizations to transform the current model for developing new diagnostics and treatments. ALS is a progressive and ultimately fatal neurological disease with few treatment options and no cure yet.

Life Science 88

Life Science Drug Development Digital Health Health Technology 88

Healthcare IT Today

DECEMBER 31, 2024

The industry is working to optimize information and data transfer between these groups, aiming to reduce redundancy and minimize manual processes that can introduce risks, whilst also generating process and product insights through technologies such as AI.

Interoperability 65

Interoperability Health IT Pharmaceuticals Digital Health 65

Healthcare IT Today

MAY 5, 2023

Technology continues to play a large role in healthcare, expediting and reducing the costs associated with the drug development process. The implementation of AI has been instrumental in significantly cutting down the drug development timeline and creating viable drug targets in a more timely and cost-efficient manner.

Drug Development 111

Drug Development Primary Care Remote care Patient Experience 111

Henry Kotula

MARCH 10, 2021

At life sciences companies, AI is primarily deployed during the drug development process to improve record-keeping and the application process, the survey found. The Consumer Technology Association (CTA) created a working group two years ago to develop some standardization on definitions and characteristics of healthcare AI.

Life Science 41

Life Science Pharmaceuticals Drug Development EHR 41

Healthcare IT Today

JANUARY 9, 2023

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Can they see changes locally in the tumor microenvironment that indicate the drug is having a biology effect? Kimberly Powell, Vice President of Healthcare at NVIDIA.

Health IT 85

Health IT Pharmaceuticals Drug Development Life Science 85